Potential capacity of aptamers to trigger immune activation in human blood.
Target specific short single-stranded DNA (ssDNA) molecules, called aptamers, are auspicious ligands for numerous in vivo applications. However, aptamers are synthetic molecules, which might be recognized by the immune cells in vivo and induce an activation of the innate immune system. Thus, immune...
Main Authors: | Meltem Avci-Adali, Heidrun Steinle, Tatjana Michel, Christian Schlensak, Hans P Wendel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3720859?pdf=render |
Similar Items
-
Rapid Complexation of Aptamers by Their Specific Antidotes
by: Heidi Stoll, et al.
Published: (2017-06-01) -
Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs
by: Heidrun Steinle, et al.
Published: (2018-12-01) -
Blood-Contacting Biomaterials: In Vitro Evaluation of the Hemocompatibility
by: Marbod Weber, et al.
Published: (2018-07-01) -
Efficient reduction of synthetic mRNA induced immune activation by simultaneous delivery of B18R encoding mRNA
by: Tatjana Michel, et al.
Published: (2019-05-01) -
Generation of iPSCs by Nonintegrative RNA-Based Reprogramming Techniques: Benefits of Self-Replicating RNA versus Synthetic mRNA
by: Heidrun Steinle, et al.
Published: (2019-01-01)